|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 47 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$617,006 |
I/I |
(48,744) |
1,151,014 |
0 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-05-26 |
4 |
B |
$6.71 |
$628,583 |
I/I |
93,322 |
15,316,021 |
2.25 |
% |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-01-09 |
4 |
B |
$8.95 |
$630,399 |
I/I |
70,449 |
4,952,506 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-02-09 |
4 |
B |
$16.93 |
$632,501 |
I/I |
36,992 |
3,936,781 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-20 |
4 |
B |
$17.88 |
$635,637 |
I/I |
35,341 |
3,664,999 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-06 |
4 |
B |
$14.16 |
$636,250 |
I/I |
44,927 |
4,345,671 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-16 |
4 |
B |
$5.80 |
$641,528 |
I/I |
110,553 |
4,190,587 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$651,092 |
I/I |
21,900 |
1,406,049 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-23 |
4 |
B |
$17.58 |
$651,492 |
I/I |
36,728 |
1,816,749 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$653,635 |
I/I |
24,582 |
1,372,864 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-01-19 |
4 |
B |
$7.12 |
$656,750 |
I/I |
92,200 |
12,393,685 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$659,464 |
I/I |
22,071 |
8,235,908 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-16 |
4 |
B |
$27.24 |
$663,310 |
I/I |
24,256 |
6,590,213 |
2.25 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-05-17 |
4 |
B |
$5.99 |
$663,571 |
I/I |
110,824 |
14,942,601 |
2.25 |
% |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-05-25 |
4 |
B |
$6.53 |
$664,135 |
I/I |
101,144 |
15,232,546 |
2.25 |
% |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-14 |
4 |
B |
$7.41 |
$664,603 |
I/I |
89,632 |
6,470,110 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-30 |
4 |
B |
$14.44 |
$665,223 |
I/I |
46,047 |
4,864,263 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-10 |
4 |
S |
$12.70 |
$666,930 |
I/I |
(52,508) |
248,829 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-06-01 |
4 |
B |
$1.58 |
$668,272 |
I/I |
407,639 |
6,840,421 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$680,782 |
I/I |
41,909 |
1,110,832 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-15 |
4 |
B |
$5.66 |
$682,811 |
I/I |
120,702 |
1,570,635 |
1.5 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-05-16 |
4 |
B |
$5.71 |
$697,839 |
I/I |
122,100 |
14,843,809 |
2.25 |
% |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-13 |
4 |
B |
$14.81 |
$703,529 |
I/I |
47,408 |
4,570,896 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-12-01 |
4 |
B |
$27.33 |
$725,256 |
I/I |
26,537 |
1,286,841 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-17 |
4 |
S |
$15.43 |
$726,394 |
I/I |
(47,053) |
1,786,851 |
0 |
- |
|
1397 Records found
|
|
Page 47 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|